Skip to content

Clinical study for the effect of individualized hemodynamic management under multi-mode circulatory monitoring with optimal cardiac output on postoperative rehabilitation of elderly patients undergoing laparoscopic surgery

Clinical study for the effect of individualized hemodynamic management under multi-mode circulatory monitoring with optimal cardiac output on postoperative rehabilitation of elderly patients undergoing laparoscopic surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900024010
Enrollment
Unknown
Registered
2019-06-22
Start date
2019-07-01
Completion date
Unknown
Last updated
2019-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodynamic management

Interventions

FloTrac/Vigileo group:Hemodynamic management by using FloTrac/Vigileo alone
Multi-mode monitoring group:Multi-mode monitoring by using TTE, TEE, and FloTrac/Vigileo in hemodynamic management

Sponsors

Beijing Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Elderly patients undergoing elective abdominal laparoscopic surgery; 2. Aged =65 years; 3. ASA I-IV.

Exclusion criteria

Exclusion criteria: 1. Patients refused; 2. Patients with atrial fibrillation or non-sinus rhythm; 3. TEE contraindications: including esophageal obstruction or stenosis, esophageal lesions;esophageal tears and perforations; esophageal diverticulum; esophageal hiatal hernia; congenital esophageal malformations; shortly after esophageal surgery; active upper gastrointestinal bleeding; 4. Patients unable to perform transthoracic echocardiography.

Design outcomes

Primary

MeasureTime frame
The amount of fluid supplemented during surgery;

Secondary

MeasureTime frame
MAP, CO, SVI, SVV after 10 minutes of intubation;MAP, CO, SVI and SVV 5 minutes before surgery;MAP, CO, SVI, SVV before and after pneumoperitoneum;Blood lactic acid and c-reactive protein peaks at 6h and 24h postoperatively;The number of days in hospital;The incidence of AKI 30 days after surgery;30-day mortality after surgery;Unobstructed survival rate within 1 year after surgery;

Countries

China

Contacts

Public ContactYu Hui

Department of Anesthesiology, Beijing Hospital

yuhuiyuki76@163.com+86 13611214036

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026